Mason will help guide and oversee the company’s market leadership and financial growth. She brings more 16 years of experience to Aurora Spine.
Prior to joining Aurora Spine, Mason was director of accounting and finance at International Stem Cell Corp., a publically traded company.
Mason began her career with Ernst and Young, working primarily in the Assurance and Advisory Business Services group. She earned a bachelor of science degree in accounting from San Diego State University in California.
Former CFO Eric Fronk has resigned from the company effective Feb. 6 to pursue other opportunities.
“We are very pleased to have someone with Sarina’s skills and experience join Aurora Spine,” said Trent J. Northcutt, president and CEO of Aurora Spine. “Sarina has a wealth of expertise in financial management as well as leadership capabilities that will be a great asset as we capitalize on the opportunities that lie ahead of us. I would like to thank outgoing CFO Eric Fronk for his substantial contributions to the company.”
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of screwless, minimally invasive, regenerative spinal implant technologies. The company has offices in the United Kingdom; Ontario, Canada; and Carlsbad, Calif.